Aims-Bacillary angiomatosis is a rare pseudoneoplastic angioproliferative lesion occurring in patients with AIDS. This condition has been associated with Bartonella henselae and Bartonella quintana infections. Human herpesvirus 8 (HHV-8) is thought to be the causative agent of Kaposi's sarcoma, a vasoproliferative neoplasm, also commonly found in patients with AIDS. The presence of HHV-8 in a cohort of patients with bacillary angiomatosis was investigated. Methods-Eight cutaneous cases of biopsy confirmed bacillary angiomatosis were assessed for HHV-8 using standard solution phase polymerase chain reaction (PCR).
Bacillary angiomatosis is a pseudoneoplastic disease characterised by angioproliferative lesions involving skin and deep viscera.
1 Virtually all cases have occurred in the setting of advanced AIDS.
2 This condition was first described in the USA in 1983 3 and in South Africa in 1993. 4 The causative organisms implicated are Bartonella henselae and Bartonella quintana 5 (formerly Rochalimea henselae and Rochalimea quintana, respectively 6 ). The newly described human herpesvirus 8 (HHV-8), 3 also known as Kaposi's sarcoma associated herpes virus (KSHV), has been shown to be associated with all forms of Kaposi's sarcoma, 7 8 including AIDS associated Kaposi's sarcoma, classic, African endemic, and the transplant associated forms. [9] [10] [11] [12] HHV-8 has also been implicated in the pathogenesis of a wide number of human neoplasms. [13] [14] [15] Bacillary angiomatosis can be clinically mistaken for Kaposi's sarcoma and although most cases demonstrate characteristic histological features ( fig 1A-C) , with lobular proliferations of capillaries, lined by plump endothelial cells associated with aggregates of neutrophils scattered throughout the lesion, occasional cases have in our experience shown areas resembling Kaposi's sarcoma ( fig 1D) .
Because both conditions are vasoformative lesions associated with infective organisms, we undertook this study to establish whether there is an association between human herpesvirus 8 and bacillary angiomatosis.
Methods
Eight cases of previously diagnosed bacillary angiomatosis, from seven patients (two separate sites from one patient), were retrieved from the archives of the department of anatomical pathology, South African Institute for Medical Research and University of the Witwatersrand. Two cases had been described previously. 4 16 Two of the patients were white homosexual men, the remaining five patients were heterosexual black Africans, who had acquired the human immunodeficiency virus sexually. No patient had biopsy confirmed Kaposi's sarcoma concurrently. Table 1 summarises the clinical details.
Sections (2-4 µm thick) were cut from paraYn wax embedded tissue, floated out, and picked up on to glass slides. These were then air dried, dewaxed, and hydrated through sequential baths of xylene and alcohol, respectively, before a final rinse in distilled water. The sections were then allowed to dry. Strict anticontamination procedures were followed.
DNA was extracted from the tissue using the QIAmp kit (Qiagen, Dorking, Surrey, UK). The tissue was digested overnight in proteinase K at 55°C, precipitated with ethanol, and bound in a spin column, before final elution in water.
Two rounds of nested polymerase chain reaction (PCR) were performed on a Perkin Elmer Geneamp PCR system (Perkin Elmer, Norwalk, Connecticut, USA). Initially, 2 µl of DNA were added to a reaction mixture containing 0.2 µM of each of the primers KS4 (5'-AGCACTCGCAGGGCAG TACG-3') and KS5 (5'-GACTCTTCGCTG ATGAACTGG-3'). Each 50 µl contained 10 mM of Tris/HCl, 50 mM of KCl, 2 mM of MgCl 2 , 1.5 U of Taq polymerase, and 0.1 mM dNTP (Boehringer Mannheim, Randburg, South Africa). A second reaction using internal primers KS1 (5'-AGCCGAAAGGATTCCA CCAT-3') and KS2 (5'-TCCGTGTT GTCTACGTCCAG-3') was performed on 4 µl of the amplimer obtained from the first reaction. The reaction mixture was identical to that used above.
Thermocycling conditions were as follows: first round: 30 cycles of 45 seconds at 94°C, 30 seconds at 60°C, and 45 seconds at 72°C. The second round was similar, but with an annealing temperature of 55°C.
Positive controls were performed, using DNA extracted from a Kaposi's sarcoma lesion, and appropriate negative controls comprised tissue not containing HHV-8 from immunocompetent patients, and a blank control with water substituted for the DNA. The DNA was electrophoresed on a 3% agarose gel and visualised with ethidium bromide. The size of the DNA fragment (233 bp) was established by comparison with a standard molecular weight marker (Marker V; Boehringer Mannheim). The sensitivity of this method has been shown to be one HHV-8 copy/10 000 uninfected cells. 17 Amplification of the -globin gene, under the same conditions described above, was performed to establish the integrity of the DNA preparations, as described previously. 18 A 10 µl aliquot of extracted DNA was amplified with primers PCO4 (5'-CAACTTCATCCACGT TCACC-3') and GH20 (5'-GAAGAGCCAAGGACAGGTAC-3'). Each reaction contained 10 mM Tris/HCl, 50 mM KCl, 4 mM MgCl 2 , 200 µM each dNTP, 2.5 U Taq polymerase, and 0.5 µM of each -globin primer.
Amplification conditions were as follows: "hot start" of 94°C for four minutes, followed by 40 cycles of 95°C for one minute, 55°C for one minute, then 72°C for one minute. The final extension was for five minutes at 72°C. The amplimers were visualised on a 3% agarose gel stained with ethidium bromide. The anticipated size of the DNA fragment was 268 bp.
Three replicate assays were performed for each sample.
Results
HHV-8 DNA sequences were not detected in the eight cases of bacillary angiomatosis. The Kaposi's sarcoma control contained HHV-8, whereas the negative controls were devoid of these DNA sequences. Figure 2 shows these results. Each of the specimens successfully amplified DNA sequences for the -globin chain, indicating that the extracted DNA was adequately preserved (fig 3) .
Discussion
Bacillary angiomatosis is a rare pseudoneoplastic vascular proliferation, occurring almost exclusively in the setting of the severe immunosuppression seen with AIDS. The role of B henselae and B quintana as the causative agents of this potentially life threatening but treatable disease is well established.
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Since the discovery of HHV-8 and the elucidation of its role in the pathogenesis of Kaposi's sarcoma, to our knowledge, there have been no studies investigating whether or not HHV-8 plays a role in the pathogenesis of bacillary angiomatosis.
Because bacillary angiomatosis and Kaposi's sarcoma are both vasoproliferative lesions, occurring in immunosuppressed individuals, it seemed logical to hypothesise that HHV-8 might play a role in the pathogenesis of bacillary angiomatosis. Indeed, controversy exists as to whether Kaposi's sarcoma is a true neoplasm or merely a reactive process induced by HHV-8. 19 In our hands, HHV-8 DNA sequences can be demonstrated in all cases of Kaposi's sarcoma (in both HIV positive and negative patients). 20 The demonstration of HHV-8 is also an extremely useful diagnostic adjunct in equivocal cases of the early patch stage of Kaposi's sarcoma. 21 In this regard, it has been suggested that the presence of HHV-8 might be a reliable marker for the diagnosis of Kaposi's sarcoma. 22 23 However, the specificity might be lower than thought initially, because of the demonstration of HHV-8 in histologically unaVected tissues in patients with Kaposi's sarcoma. 23 Furthermore, a study has also demonstrated the presence of HHV-8 in prostatic tissues of non-immunosuppressed patients. 24 However, this has not been confirmed in other studies. 25 26 Other vascular tumours can mimic Kaposi's sarcoma histologically, particularly angiosarcomas, spindle cell haemangioendothelioma, and kaposiform haemangioendothelioma. The absence of HHV-8 DNA sequences in these lesions, as well as their absence in a range of other vascular neoplasms, has also been demonstrated. 27 Thus, the demonstration of HHV-8 in a vascular lesion with the histomorphology of Kaposi's sarcoma should be regarded as being specific for Kaposi's sarcoma.
Our data indicate that HHV-8 is not associated with bacillary angiomatosis. For practical purposes this might have useful implications for histopathologists, in distinguishing between these two entities. Bacillary angiomatosis, in most instances, has characteristic histopathological features, which allow it to be distinguished from Kaposi's sarcoma. In our experience, occasional cases of bacillary angiomatosis can show areas within the lesion that are virtually indistinguishable from Kaposi's sarcoma.
In cases in which histological diVerentiation between these two vasoproliferative lesions is not clear, the demonstration of HHV-8 could definitively establish the diagnosis of Kaposi's sarcoma. In contradistinction, the demonstration of HHV-8 would be against a diagnosis of bacillary angiomatosis. This distinction has important clinical implications, because bacillary angiomatosis responds well to appropriate antibiotic treatment, the insitution of which may be lifesaving.
In summary, we have shown that bacillary angiomatosis is not associated with HHV-8. This finding supports the growing body of evidence that HHV-8 is a specific marker for Kaposi's sarcoma, and is not found in other vasoproliferative lesions and tumours. 
